1. Home
  2. LCTX vs AVNW Comparison

LCTX vs AVNW Comparison

Compare LCTX & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

N/A

Current Price

$0.79

Market Cap

251.4M

Sector

Health Care

ML Signal

N/A

Logo Aviat Networks Inc.

AVNW

Aviat Networks Inc.

N/A

Current Price

$15.77

Market Cap

255.9M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
LCTX
AVNW
Founded
1990
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
251.4M
255.9M
IPO Year
1996
2007

Fundamental Metrics

Financial Performance
Metric
LCTX
AVNW
Price
$0.79
$15.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
8
Target Price
$5.50
★ $32.38
AVG Volume (30 Days)
★ 2.1M
168.0K
Earning Date
11-12-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 90.00
EPS
★ N/A
N/A
Revenue
$14,556,000.00
★ $243,858,000.00
Revenue This Year
$4.38
$5.07
Revenue Next Year
$10.80
$5.98
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 53.24
0.56
52 Week Low
$0.77
$13.92
52 Week High
$1.99
$27.02

Technical Indicators

Market Signals
Indicator
LCTX
AVNW
Relative Strength Index (RSI) 34.81 35.70
Support Level N/A $14.70
Resistance Level $1.16 $20.66
Average True Range (ATR) 0.08 1.27
MACD -0.03 -0.19
Stochastic Oscillator 2.86 8.30

Price Performance

Historical Comparison
LCTX
AVNW

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

About AVNW Aviat Networks Inc.

Aviat Networks Inc manufacture and sell a range of wireless transport and access networking products, solutions and services to two principal customer types. Communications Service Providers (CSPs): These include mobile and fixed telecommunications network operators, broadband and internet service providers and network operators which generate revenues from the communications services. Private network operators: These are customers which do not resell communications services but build networks for reasons of economics, autonomy, and/or security to support a wide variety of mission critical performance applications. Examples include federal, state and local government agencies, transportation agencies, energy and utility companies, public safety agencies and broadcast network operators.

Share on Social Networks: